These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 31182003)

  • 1. Role of Descending Dopaminergic Pathways in Pain Modulation.
    Li C; Liu S; Lu X; Tao F
    Curr Neuropharmacol; 2019; 17(12):1176-1182. PubMed ID: 31182003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GABA(A) receptors in the ventral tegmental area control bidirectional reward signalling between dopaminergic and non-dopaminergic neural motivational systems.
    Laviolette SR; van der Kooy D
    Eur J Neurosci; 2001 Mar; 13(5):1009-15. PubMed ID: 11264674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopaminergic and serotonergic mechanisms in the modulation of pain: In vivo studies in human brain.
    Martikainen IK; Hagelberg N; Jääskeläinen SK; Hietala J; Pertovaara A
    Eur J Pharmacol; 2018 Sep; 834():337-345. PubMed ID: 30036531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tonic and phasic descending dopaminergic controls of nociceptive transmission in the medullary dorsal horn.
    Lapirot O; Melin C; Modolo A; Nicolas C; Messaoudi Y; Monconduit L; Artola A; Luccarini P; Dallel R
    Pain; 2011 Aug; 152(8):1821-1831. PubMed ID: 21514054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of central dopamine in pain and analgesia.
    Wood PB
    Expert Rev Neurother; 2008 May; 8(5):781-97. PubMed ID: 18457535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibromyalgia patients show an abnormal dopamine response to pain.
    Wood PB; Schweinhardt P; Jaeger E; Dagher A; Hakyemez H; Rabiner EA; Bushnell MC; Chizh BA
    Eur J Neurosci; 2007 Jun; 25(12):3576-82. PubMed ID: 17610577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Critical Role for Dopamine D5 Receptors in Pain Chronicity in Male Mice.
    Megat S; Shiers S; Moy JK; Barragan-Iglesias P; Pradhan G; Seal RP; Dussor G; Price TJ
    J Neurosci; 2018 Jan; 38(2):379-397. PubMed ID: 29167404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine: Functions, Signaling, and Association with Neurological Diseases.
    Klein MO; Battagello DS; Cardoso AR; Hauser DN; Bittencourt JC; Correa RG
    Cell Mol Neurobiol; 2019 Jan; 39(1):31-59. PubMed ID: 30446950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basal Ganglia Neuromodulation Over Multiple Temporal and Structural Scales-Simulations of Direct Pathway MSNs Investigate the Fast Onset of Dopaminergic Effects and Predict the Role of Kv4.2.
    Lindroos R; Dorst MC; Du K; Filipović M; Keller D; Ketzef M; Kozlov AK; Kumar A; Lindahl M; Nair AG; Pérez-Fernández J; Grillner S; Silberberg G; Hellgren Kotaleski J
    Front Neural Circuits; 2018; 12():3. PubMed ID: 29467627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The hypothalamic-spinal dopaminergic system: a target for pain modulation.
    Puopolo M
    Neural Regen Res; 2019 Jun; 14(6):925-930. PubMed ID: 30761995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stress and the dopaminergic reward system.
    Baik JH
    Exp Mol Med; 2020 Dec; 52(12):1879-1890. PubMed ID: 33257725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopaminergic modulation of pain signals in the medial prefrontal cortex: Challenges and perspectives.
    Huang S; Borgland SL; Zamponi GW
    Neurosci Lett; 2019 May; 702():71-76. PubMed ID: 30503912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential nicotinic regulation of the nigrostriatal and mesolimbic dopaminergic pathways: implications for drug development.
    Janhunen S; Ahtee L
    Neurosci Biobehav Rev; 2007; 31(3):287-314. PubMed ID: 17141870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of dopamine in the primate caudate nucleus in reward modulation of saccades.
    Nakamura K; Hikosaka O
    J Neurosci; 2006 May; 26(20):5360-9. PubMed ID: 16707788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine receptor D2, but not D1, mediates descending dopaminergic pathway-produced analgesic effect in a trigeminal neuropathic pain mouse model.
    Liu S; Tang Y; Shu H; Tatum D; Bai Q; Crawford J; Xing Y; Lobo MK; Bellinger L; Kramer P; Tao F
    Pain; 2019 Feb; 160(2):334-344. PubMed ID: 30325872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pain-related opioidergic and dopaminergic neurotransmission: Dual meta-Analyses of PET radioligand studies.
    Garcia Guerra S; Spadoni A; Mitchell J; Strigo IA
    Brain Res; 2023 Apr; 1805():148268. PubMed ID: 36754138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine and Huntington's disease.
    Schwab LC; Garas SN; Drouin-Ouellet J; Mason SL; Stott SR; Barker RA
    Expert Rev Neurother; 2015 Apr; 15(4):445-58. PubMed ID: 25773746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopaminergic input to GABAergic neurons in the rostral agranular insular cortex of the rat.
    Ohara PT; Granato A; Moallem TM; Wang BR; Tillet Y; Jasmin L
    J Neurocytol; 2003 Feb; 32(2):131-41. PubMed ID: 14707548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the dopamine system in the brain of the túngara frog, Physalaemus pustulosus.
    O'Connell LA; Matthews BJ; Ryan MJ; Hofmann HA
    Brain Behav Evol; 2010; 76(3-4):211-25. PubMed ID: 21099197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there a role for ghrelin in central dopaminergic systems? Focus on nigrostriatal and mesocorticolimbic pathways.
    Stievenard A; Méquinion M; Andrews ZB; Destée A; Chartier-Harlin MC; Viltart O; Vanbesien-Mailliot CC
    Neurosci Biobehav Rev; 2017 Feb; 73():255-275. PubMed ID: 27914942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.